{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:28:35Z","timestamp":1780676915655,"version":"3.54.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10787-025-02015-2","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:53:04Z","timestamp":1761202384000},"page":"7107-7122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic perspective of postbiotics in managing health of women with polycystic ovarian syndrome: a holistic approach"],"prefix":"10.1007","volume":"33","author":[{"given":"Anwesa","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh Ajit","family":"Kolekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MVNL","family":"Chaitanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepshikha","family":"Patle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-6572","authenticated-orcid":false,"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"publisher","first-page":"103244","DOI":"10.1016\/j.jri.2020.103244","volume":"143","author":"A Abbasi","year":"2021","unstructured":"Abbasi A, Aghebati-Maleki A, Yousefi M, Aghebati-Maleki L (2021) Probiotic intervention as a potential therapeutic for managing gestational disorders and improving pregnancy outcomes. J Reprod Immunol 143:103244. https:\/\/doi.org\/10.1016\/j.jri.2020.103244","journal-title":"J Reprod Immunol"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A (2021) Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet 303:631\u2013643. https:\/\/doi.org\/10.1007\/s00404-020-05951-2","journal-title":"Arch Gynecol Obstet"},{"key":"2015_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103009","author":"S Alesi","year":"2025","unstructured":"Alesi S, Forslund M, Melin J, Romualdi D, Pe\u00f1a A, Tay CT, Witchel SF, Teede H, Mousa A (2025) Correction of meta-analysis after retraction of article on the effects of anti-androgens in polycystic ovary syndrome. eClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103009","journal-title":"eClinicalMedicine"},{"key":"2015_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0301707","volume":"19","author":"Z Alkheyr","year":"2024","unstructured":"Alkheyr Z, Murad M, Das P, Aljenaee K, Kamel C, Hajji SA, Flood J, Atkin SL, Ali KF (2024) Self-esteem and body image satisfaction in women with PCOS in the Middle East: cross-sectional social media study. PLoS ONE 19:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0301707","journal-title":"PLoS ONE"},{"key":"2015_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11274-025-04483-8","volume":"41","author":"A Amobonye","year":"2025","unstructured":"Amobonye A, Pillay B, Hlope F, Asong ST, Pillai S (2025) Postbiotics: an insightful review of the latest category in functional biotics. World J Microbiol Biotechnol 41:293. https:\/\/doi.org\/10.1007\/s11274-025-04483-8","journal-title":"World J Microbiol Biotechnol"},{"key":"2015_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1141355","author":"P Angoorani","year":"2023","unstructured":"Angoorani P, Ejtahed HS, Ettehad Marvasti F, Taghavi MS, Mohammadpour Ahranjani B, Hasani-Ranjbar S, Larijani B (2023) The effects of probiotics prebiotics and synbiotics on polycystic ovarian syndrome an overview of systematic reviews. Front Med. https:\/\/doi.org\/10.3389\/fmed.2023.1141355","journal-title":"Front Med"},{"key":"2015_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084110","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on Insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23084110","journal-title":"Int J Mol Sci"},{"key":"2015_CR8","doi-asserted-by":"publisher","first-page":"102236","DOI":"10.1016\/j.arr.2024.102236","volume":"95","author":"B Bashir","year":"2024","unstructured":"Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P (2024) Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Res Rev 95:102236","journal-title":"Ageing Res Rev"},{"key":"2015_CR9","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.arr.2025.102689","volume":"105","author":"B Bashir","year":"2025","unstructured":"Bashir B, Gulati M, Vishwas S, Gupta G, Dhanasekaran M, Paudel KR, Chellappan DK, Anand K, Negi P, Singh PK, Rajput A, Dua K, Singh SK (2025) Bridging gap in the treatment of Alzheimer\u2019s disease via postbiotics: current practices and future prospects. Ageing Res Rev 105:102689. https:\/\/doi.org\/10.1016\/j.arr.2025.102689","journal-title":"Ageing Res Rev"},{"key":"2015_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.dld.2018.02.012","volume":"50","author":"C Binda","year":"2018","unstructured":"Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A (2018) Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig Liver Dis 50:421\u2013428. https:\/\/doi.org\/10.1016\/j.dld.2018.02.012","journal-title":"Dig Liver Dis"},{"key":"2015_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143144","author":"V Calcaterra","year":"2023","unstructured":"Calcaterra V, Rossi V, Massini G, Casini F, Zuccotti G, Fabiano V (2023) Probiotics and polycystic ovary syndrome: a perspective for management in adolescents with obesity. Nutrients. https:\/\/doi.org\/10.3390\/nu15143144","journal-title":"Nutrients"},{"key":"2015_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203255","author":"E Carmina","year":"2022","unstructured":"Carmina E, Longo RA (2022) Increased prevalence of elevated DHEAS in PCOS women with non-classic (B or C) phenotypes: a retrospective analysis in patients aged 20 to 29 years. Cells. https:\/\/doi.org\/10.3390\/cells11203255","journal-title":"Cells"},{"key":"2015_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/uog.11202","volume":"40","author":"S Catteau-Jonard","year":"2012","unstructured":"Catteau-Jonard S, Bancquart J, Poncelet E, Lefebvre-Maunoury C, Robin G, Dewailly D (2012) Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome? Ultrasound Obstet Gynecol 40:223\u2013229. https:\/\/doi.org\/10.1002\/uog.11202","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2015_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/IJWH.S345853","volume":"14","author":"X Cheng","year":"2022","unstructured":"Cheng X, He B (2022) Clinical and biochemical potential of antioxidants in treating polycystic ovary syndrome. Int J Womens Health 14:467\u2013479. https:\/\/doi.org\/10.2147\/IJWH.S345853","journal-title":"Int J Womens Health"},{"key":"2015_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020197","author":"L Corrie","year":"2023","unstructured":"Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur IP, Gupta G, Kommineni N, Dua K, Singh SK (2023) Interplay of gut microbiota in polycystic ovarian syndrome: role of gut microbiota, mechanistic pathways and potential treatment strategies. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16020197","journal-title":"Pharmaceuticals (Basel)"},{"key":"2015_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-022-01208-y","volume":"23","author":"S Cowan","year":"2023","unstructured":"Cowan S, Lim S, Alycia C, Pirotta S, Thomson R, Gibson-Helm M, Blackmore R, Naderpoor N, Bennett C, Ee C, Rao V, Mousa A, Alesi S, Moran L (2023) Lifestyle management in polycystic ovary syndrome \u2013 beyond diet and physical activity. BMC Endocr Disord 23:1\u201333. https:\/\/doi.org\/10.1186\/s12902-022-01208-y","journal-title":"BMC Endocr Disord"},{"key":"2015_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijpvm.IJPVM","volume":"8","author":"A Davoudi-Kiakalayeh","year":"2017","unstructured":"Davoudi-Kiakalayeh A, Mohammadi R, Pourfathollah AA, Siery Z, Davoudi-Kiakalayeh S (2017) Alloimmunization in thalassemia patients: New insight for healthcare. Int J Prev Med 8:1\u20134. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM","journal-title":"Int J Prev Med"},{"issue":"3","key":"2015_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ijtm5030030","volume":"5","author":"OO Deji-oloruntoba","year":"2025","unstructured":"Deji-oloruntoba OO, Balogun JO, Elufioye TO, Ajakwe SO (2025) Hyperuricemia and insulin resistance: interplay and potential for targeted therapies. Int. J. Transl. Med 5(3):30. https:\/\/doi.org\/10.3390\/ijtm5030030","journal-title":"Int. J. Transl. Med"},{"key":"2015_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2024.1470283","volume":"15","author":"H Deng","year":"2024","unstructured":"Deng H, Chen Y, Xing J, Zhang N, Xu L (2024) Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front Immunol 15:1\u201320. https:\/\/doi.org\/10.3389\/fimmu.2024.1470283","journal-title":"Front Immunol"},{"key":"2015_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q (2021a) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne) 12:1\u201314. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR21","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q (2021b) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne) 12:741764. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40104-024-01098-1","volume":"15","author":"ME Duarte","year":"2024","unstructured":"Duarte ME, Deng Z, Kim SW (2024) Effects of dietary Lactobacillus postbiotics and bacitracin on the modulation of mucosa-associated microbiota and pattern recognition receptors affecting immunocompetence of jejunal mucosa in pigs challenged with enterotoxigenic F18(+) Escherichia coli. J Anim Sci Biotechnol 15:139. https:\/\/doi.org\/10.1186\/s40104-024-01098-1","journal-title":"J Anim Sci Biotechnol"},{"key":"2015_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015) Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 36:487\u2013525. https:\/\/doi.org\/10.1210\/er.2015-1018","journal-title":"Endocr Rev"},{"key":"2015_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12868-023-00834-z","volume":"24","author":"O-I Eepho","year":"2023","unstructured":"Eepho O-I, Bashir A-AM, Oniyide AA, Aturamu A, Owolabi OV, Ajadi IO, Fafure AA, Ajadi MB, Areloegbe SE, Olaniyi KS (2023) Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS. BMC Neurosci 24:62. https:\/\/doi.org\/10.1186\/s12868-023-00834-z","journal-title":"BMC Neurosci"},{"issue":"2","key":"2015_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3164\/jcbn.24-178","volume":"76","author":"T Sato","year":"2024","unstructured":"Sato T, Tomizawa M, Segawa S, Matsuoka M, Aurues T (2024) Effect of 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4H-pyran-4-one-containing lactic acid bacterial beverages on skin moisture: a randomized, double-blind, placebo-controlled, parallel study. J Clin Biochem Nutr. 76(2):195\u2013201. https:\/\/doi.org\/10.3164\/jcbn.24-178","journal-title":"J Clin Biochem Nutr."},{"key":"2015_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 14:270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"2015_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2025.1604302","volume":"16","author":"X Feng","year":"2025","unstructured":"Feng X, Xiao J, Wang D, Fu X, Gao J, Jiang M, Li J, Jiang L, Liang X, Huang Y, Jiang Q (2025a) Butyric acid ameliorates PCOS-related reproductive dysfunction through gut-brain-ovary axis signaling and ovarian steroidogenic factor activation. Front Endocrinol (Lausanne) 16:1\u201318. https:\/\/doi.org\/10.3389\/fendo.2025.1604302","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR28","doi-asserted-by":"publisher","first-page":"1604302","DOI":"10.3389\/fendo.2025.1604302","volume":"16","author":"X Feng","year":"2025","unstructured":"Feng X, Xiao J, Wang D, Fu X, Gao J, Jiang M, Li J, Jiang L, Liang X, Huang Y, Jiang Q (2025b) Butyric acid ameliorates PCOS-related reproductive dysfunction through gut-brain-ovary axis signaling and ovarian steroidogenic factor activation. Front Endocrinol (Lausanne) 16:1604302. https:\/\/doi.org\/10.3389\/fendo.2025.1604302","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu17020310","author":"R Gautam","year":"2025","unstructured":"Gautam R, Maan P, Jyoti A, Kumar A, Malhotra N, Arora T (2025) The role of lifestyle interventions in PCOS management: a systematic review. Nutrients. https:\/\/doi.org\/10.3390\/nu17020310","journal-title":"Nutrients"},{"key":"2015_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E (2015) American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - Part 1. Endocr Pract 21:1291\u20131300. https:\/\/doi.org\/10.4158\/EP15748.DSC","journal-title":"Endocr Pract"},{"key":"2015_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-024-01448-7","volume":"17","author":"M Gu","year":"2024","unstructured":"Gu M, Wang Y, Yu Y (2024a) Ovarian fibrosis: molecular mechanisms and potential therapeutic targets. J Ovarian Res 17:1\u201312. https:\/\/doi.org\/10.1186\/s13048-024-01448-7","journal-title":"J Ovarian Res"},{"key":"2015_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13048-024-01448-7","volume":"17","author":"M Gu","year":"2024","unstructured":"Gu M, Wang Y, Yu Y (2024b) Ovarian fibrosis: molecular mechanisms and potential therapeutic targets. J Ovarian Res 17:139. https:\/\/doi.org\/10.1186\/s13048-024-01448-7","journal-title":"J Ovarian Res"},{"key":"2015_CR33","doi-asserted-by":"publisher","first-page":"105130","DOI":"10.1016\/j.tifs.2025.105130","volume":"163","author":"S Guglielmetti","year":"2025","unstructured":"Guglielmetti S, Boyte ME, Smith CL, Ouwehand AC, Paraskevakos G, Younes JA (2025) Commercial and regulatory frameworks for postbiotics: an industry-oriented scientific perspective for non-viable microbial ingredients conferring beneficial physiological effects. Trends Food Sci Technol 163:105130. https:\/\/doi.org\/10.1016\/j.tifs.2025.105130","journal-title":"Trends Food Sci Technol"},{"key":"2015_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-025-03930-w","author":"\u00d6 G\u00fcl","year":"2025","unstructured":"G\u00fcl \u00d6, Akku\u015f M, Akku\u015f F (2025) Depression, anxiety, and stress in polycystic ovary syndrome: understanding the impact of adult separation anxiety and uncertainty intolerance. BMC Womens Health. https:\/\/doi.org\/10.1186\/s12905-025-03930-w","journal-title":"BMC Womens Health"},{"key":"2015_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jsbmb.2015.04.008","volume":"153","author":"JA Gustafsson","year":"2015","unstructured":"Gustafsson JA (2015) Control of gene expression by novel metabolic intermediates. J Steroid Biochem Mol Biol 153:102\u2013104. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2015_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","volume":"13","author":"F-F He","year":"2020","unstructured":"He F-F, Li Y-M (2020) Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res 13:73. https:\/\/doi.org\/10.1186\/s13048-020-00670-3","journal-title":"J Ovarian Res"},{"key":"2015_CR37","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1039\/c9fo02554e","volume":"11","author":"Y He","year":"2020","unstructured":"He Y, Wang Q, Li X, Wang G, Zhao J, Zhang H, Chen W (2020) Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota. Food Funct 11:5192\u20135204. https:\/\/doi.org\/10.1039\/c9fo02554e","journal-title":"Food Funct"},{"key":"2015_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI162315","volume":"133","author":"C Huang","year":"2023","unstructured":"Huang C, Zhao S, Yang Y, Guo T, Ke H, Mi X, Qin Y, Chen ZJ, Zhao S (2023) TP63 gain-of-function mutations cause premature ovarian insufficiency by inducing oocyte apoptosis. J Clin Invest 133:1\u201314. https:\/\/doi.org\/10.1172\/JCI162315","journal-title":"J Clin Invest"},{"key":"2015_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom13071101","volume":"13","author":"T Jing","year":"2023","unstructured":"Jing T, Wu Y, Wan A, Ge C, Chen ZJ, Du Y (2023) Circular RNA as a novel regulator and promising biomarker in polycystic ovary syndrome. Biomolecules 13:1\u201319. https:\/\/doi.org\/10.3390\/biom13071101","journal-title":"Biomolecules"},{"key":"2015_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163652","author":"J Jurczewska","year":"2023","unstructured":"Jurczewska J, Ostrowska J, Che\u0142chowska M, Panczyk M, Rudnicka E, Kucharski M, Smolarczyk R, Szostak-W\u0119gierek D (2023) Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study. Nutrients. https:\/\/doi.org\/10.3390\/nu15163652","journal-title":"Nutrients"},{"key":"2015_CR41","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s12602-023-10184-1","volume":"16","author":"N khani","year":"2024","unstructured":"khani N, Noorkhajavi G, Reziabad RH, Rad AH, Ziavand M (2024) Postbiotics as potential detoxification tools for mitigation of pesticides. Probiotics Antimicrob Proteins 16:1427\u20131439. https:\/\/doi.org\/10.1007\/s12602-023-10184-1","journal-title":"Probiotics Antimicrob Proteins"},{"key":"2015_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-023-00563-y","volume":"15","author":"G Kilic Yildirim","year":"2023","unstructured":"Kilic Yildirim G, Dinleyici M, Vandenplas Y, Dinleyici EC (2023) Effects of synbiotic supplementation on intestinal microbiota composition in children and adolescents with exogenous obesity: (Probesity-2 trial). Gut Pathog 15:1\u201312. https:\/\/doi.org\/10.1186\/s13099-023-00563-y","journal-title":"Gut Pathog"},{"key":"2015_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4110\/in.2014.14.6.277","volume":"14","author":"CH Kim","year":"2014","unstructured":"Kim CH, Park J, Kim M (2014) Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw 14:277. https:\/\/doi.org\/10.4110\/in.2014.14.6.277","journal-title":"Immune Netw"},{"key":"2015_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081037","author":"H Koike","year":"2022","unstructured":"Koike H, Harada M, Kusamoto A, Kunitomi C, Xu Z, Tanaka T, Urata Y, Nose E, Takahashi N, Wada-Hiraike O, Hirota Y, Koga K, Osuga Y (2022) Notch signaling induced by endoplasmic reticulum stress regulates cumulus-oocyte complex expansion in polycystic ovary syndrome. Biomolecules. https:\/\/doi.org\/10.3390\/biom12081037","journal-title":"Biomolecules"},{"key":"2015_CR45","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.steroids.2012.05.003","volume":"77","author":"D Kov\u00e1cs","year":"2012","unstructured":"Kov\u00e1cs D, K\u00e1d\u00e1r Z, M\u00f3ty\u00e1n G, Schneider G, W\u00f6lfling J, Zupk\u00f3 I, Frank \u00c9 (2012) Synthesis, characterization and biological evaluation of some novel 17-isoxazoles in the estrone series. Steroids 77:1075\u20131085. https:\/\/doi.org\/10.1016\/j.steroids.2012.05.003","journal-title":"Steroids"},{"key":"2015_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/foods13182937","author":"A Kumar","year":"2024","unstructured":"Kumar A, Green KM, Rawat M (2024) A comprehensive overview of postbiotics with a special focus on discovery techniques and clinical applications. Foods. https:\/\/doi.org\/10.3390\/foods13182937","journal-title":"Foods"},{"key":"2015_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/978-981-99-5575-6_22","volume-title":"Synbiotics in Human Health: Biology to Drug Delivery","author":"P Kumbhar","year":"2024","unstructured":"Kumbhar P, Kolekar K, Patil R, Rhatwal R, Singh SK, Dua K, Patravale V, Disouza J (2024) Advanced Drug Delivery Approaches Containing Synbiotics. Synbiotics in Human Health: Biology to Drug Delivery. Springer, Singapore, pp 459\u2013472"},{"key":"2015_CR48","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/S00210-024-03578-7","volume":"398","author":"PS Kumbhar","year":"2025","unstructured":"Kumbhar PS, Chavan R, Darekar S, Kolekar K, Sequeira A, Vishwas S, Gupta G, Paudel KR, Singh SK, Dua K, Disouza J, Patravale V (2025) Bridging gap in treatment of polycystic ovarian syndrome through drug repurposing: what we achieved and where we are? Naunyn Schmiedebergs Arch Pharmacol 398:3213\u20133240. https:\/\/doi.org\/10.1007\/S00210-024-03578-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2015_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/HCM.0000000000000302","volume":"39","author":"EJ Layman","year":"2020","unstructured":"Layman EJ (2020) Ethical issues and the electronic health record. Health Care Manage 39:150\u2013161. https:\/\/doi.org\/10.1097\/HCM.0000000000000302","journal-title":"Health Care Manage"},{"key":"2015_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2025.1529703","volume":"16","author":"C Li","year":"2025","unstructured":"Li C, Cheng D, Ren H, Zhang T (2025) Unraveling the gut microbiota\u2019s role in PCOS: a new frontier in metabolic health. Front Endocrinol (Lausanne) 16:1\u201311. https:\/\/doi.org\/10.3389\/fendo.2025.1529703","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR51","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"B Liao","year":"2021","unstructured":"Liao B, Qiao J, Pang Y (2021) Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol (Lausanne) 12:667422. https:\/\/doi.org\/10.3389\/fendo.2021.667422","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR52","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2147\/IJWH.S522708","volume":"17","author":"S Liu","year":"2025","unstructured":"Liu S, Cheng L, Li S (2025) Characteristics of gut microbiota in patients with polycystic ovary syndrome and its association with metabolic abnormalities: a review. Int J Womens Health 17:2165\u20132174. https:\/\/doi.org\/10.2147\/IJWH.S522708","journal-title":"Int J Womens Health"},{"key":"2015_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030560","author":"CE L\u0151rincz","year":"2024","unstructured":"L\u0151rincz CE, B\u00f6rzsei D, Hoffmann A, Varga C, Szab\u00f3 R (2024) Mechanisms and target parameters in relation to polycystic ovary syndrome and physical exercise: focus on the master triad of hormonal changes, oxidative stress, and inflammation. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12030560","journal-title":"Biomedicines"},{"key":"2015_CR54","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.clnu.2024.04.032","volume":"43","author":"A Luzzi","year":"2024","unstructured":"Luzzi A, Briata IM, Di Napoli I, Giugliano S, Di Sabatino A, Rescigno M, Cena H (2024) Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome. Clin Nutr 43:1433\u20131446. https:\/\/doi.org\/10.1016\/j.clnu.2024.04.032","journal-title":"Clin Nutr"},{"key":"2015_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030709","author":"J Mahabamunuge","year":"2025","unstructured":"Mahabamunuge J, Sekula NM, Lepore C, Kudrimoti M, Upadhyay A, Alshowaikh K, Li HJ, Seifer DB, AlAshqar A (2025) The molecular basis of polycystic ovary syndrome and its cardiometabolic correlates: exploring the intersection and its clinical implications-a narrative review. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13030709","journal-title":"Biomedicines"},{"key":"2015_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041667","volume":"22","author":"A Mancini","year":"2021","unstructured":"Mancini A, Bruno C, Vergani E, D\u2019abate C, Giacchi E, Silvestrini A (2021) Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights. Int J Mol Sci 22:1\u201316. https:\/\/doi.org\/10.3390\/ijms22041667","journal-title":"Int J Mol Sci"},{"key":"2015_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu16223916","volume":"16","author":"D Martinez Guevara","year":"2024","unstructured":"Martinez Guevara D, Vidal Ca\u00f1as S, Palacios I, G\u00f3mez A, Estrada M, Gallego J, Liscano Y (2024) Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with polycystic ovary syndrome (PCOS): a systematic review of randomized clinical trials. Nutr 16:1\u201328. https:\/\/doi.org\/10.3390\/nu16223916","journal-title":"Nutr"},{"key":"2015_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061586","author":"B Mi\u0107i\u0107","year":"2023","unstructured":"Mi\u0107i\u0107 B, Djordjevic A, Veli\u010dkovi\u0107 N, Kova\u010devi\u0107 S, Marti\u0107 T, Macut D, Vojnovi\u0107 Milutinovi\u0107 D (2023) AMPK activation as a protective mechanism to restrain oxidative stress in the insulin-resistant state in skeletal muscle of rat model of PCOS subjected to postnatal overfeeding. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11061586","journal-title":"Biomedicines"},{"key":"2015_CR59","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0529","author":"M Monney","year":"2025","unstructured":"Monney M, Mavromati M, Leboulleux S, Gariani K (2025) Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review. Endocr Connect. https:\/\/doi.org\/10.1530\/EC-24-0529","journal-title":"Endocr Connect"},{"key":"2015_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2117508","author":"A Mosca","year":"2022","unstructured":"Mosca A, Abreu Y Abreu AT, Gwee KA, Ianiro G, Tack J, Nguyen TVH, Hill C (2022) The clinical evidence for postbiotics as microbial therapeutics. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2022.2117508","journal-title":"Gut Microbes"},{"key":"2015_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.17727\/jmsr.2023\/11-10","volume":"11","author":"P N","year":"2023","unstructured":"N P, D S, V L, Ia S (2023) Polycystic ovarian syndrome and microbiome: implications for women\u2019s health. J Med Sci Res 11:47\u201356. https:\/\/doi.org\/10.17727\/jmsr.2023\/11-10","journal-title":"J Med Sci Res"},{"key":"2015_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0272124","volume":"17","author":"KS Olaniyi","year":"2022","unstructured":"Olaniyi KS, Bashir AAM, Areloegbe SE, Sabinari IW, Akintayo CO, Oniyide AA, Aturamu A (2022) Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model. PLoS ONE 17:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0272124","journal-title":"PLoS ONE"},{"key":"2015_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13104-024-06921-6","volume":"17","author":"KS Olaniyi","year":"2024","unstructured":"Olaniyi KS, Agan SU, Areloegbe SE, Sabinari IW, Oniyide AA, Enye LA, Omoaghe AO, Adekeye AO, Adeoluwa OA (2024) Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome. BMC Res Notes 17:260. https:\/\/doi.org\/10.1186\/s13104-024-06921-6","journal-title":"BMC Res Notes"},{"key":"2015_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1324429","volume":"14","author":"M Orisaka","year":"2023","unstructured":"Orisaka M, Mizutani T, Miyazaki Y, Shirafuji A, Tamamura C, Fujita M, Tsuyoshi H, Yoshida Y (2023) Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front Endocrinol (Lausanne) 14:1\u20138. https:\/\/doi.org\/10.3389\/fendo.2023.1324429","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR65","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/IJWH.S70314","volume":"7","author":"S Palomba","year":"2015","unstructured":"Palomba S, Santagni S, Falbo A, La Sala GB (2015) Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health 7:745\u2013763. https:\/\/doi.org\/10.2147\/IJWH.S70314","journal-title":"Int J Womens Health"},{"key":"2015_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105423","author":"S Parambath","year":"2024","unstructured":"Parambath S, Selvraj NR, Venugopal P, Aradhya R (2024) Notch signaling: an emerging paradigm in the pathogenesis of reproductive disorders and diverse pathological conditions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25105423","journal-title":"Int J Mol Sci"},{"key":"2015_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076414","author":"SJ Park","year":"2023","unstructured":"Park SJ, Sharma A, Lee HJ (2023) Postbiotics against obesity: perception and overview based on pre-clinical and clinical studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076414","journal-title":"Int J Mol Sci"},{"key":"2015_CR68","doi-asserted-by":"publisher","first-page":"e48929","DOI":"10.7759\/cureus.48929","volume":"15","author":"A Patel","year":"2023","unstructured":"Patel A, Dewani D, Jaiswal A, Yadav P, Reddy LS (2023) Exploring melatonin\u2019s multifaceted role in polycystic ovary syndrome management: a comprehensive review. Cureus 15:e48929. https:\/\/doi.org\/10.7759\/cureus.48929","journal-title":"Cureus"},{"key":"2015_CR69","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s12325-018-0810-1","volume":"35","author":"E Reyes-Mu\u00f1oz","year":"2018","unstructured":"Reyes-Mu\u00f1oz E, Sathyapalan T, Rossetti P, Shah M, Long M, Buscema M, Valenti G, La Rosa VL, Cianci S, Vitale SG (2018) Polycystic ovary syndrome: implication for drug metabolism on assisted reproductive techniques-a literature review. Adv Ther 35:1805\u20131815. https:\/\/doi.org\/10.1007\/s12325-018-0810-1","journal-title":"Adv Ther"},{"key":"2015_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073789","journal-title":"Int J Mol Sci"},{"key":"2015_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M (2022) Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020583","journal-title":"Int J Mol Sci"},{"key":"2015_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06315-7","author":"H Senthilkumar","year":"2025","unstructured":"Senthilkumar H, Arumugam M (2025) Gut microbiota: a hidden player in polycystic ovary syndrome. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-025-06315-7","journal-title":"J Transl Med"},{"key":"2015_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04116-4","author":"S Shabbir","year":"2023","unstructured":"Shabbir S, Khurram E, Moorthi VS, Tamer Y, Eissa H (2023) The interplay between androgens and the immune response in polycystic ovary syndrome. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-023-04116-4","journal-title":"J Transl Med"},{"key":"2015_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.arr.2025.102888","volume":"112","author":"S Sharma","year":"2025","unstructured":"Sharma S, Bashir B, Kolekar KA, Acharya A, Gupta M, Jena R, Vishwas S, Kaur J, Gupta G, Kumbhar PS (2025) Tailoring the biomarkers of Alzheimer\u2019s disease using a gut microbiome-centric approach: preclinical, clinical, and regulatory perspectives. Ageing Res. Rev. 112:12. https:\/\/doi.org\/10.1016\/j.arr.2025.102888","journal-title":"Ageing Res. Rev."},{"key":"2015_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454","author":"S Singh","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M (2023) Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12041454","journal-title":"J Clin Med"},{"key":"2015_CR76","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/jn\/nxaa077","volume":"150","author":"LT Stiemsma","year":"2020","unstructured":"Stiemsma LT, Nakamura RE, Nguyen JG, Michels KB (2020) Does consumption of fermented foods modify the human gut microbiota? J Nutr 150:1680\u20131692. https:\/\/doi.org\/10.1093\/jn\/nxaa077","journal-title":"J Nutr"},{"key":"2015_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-025-01621-6","author":"P Su","year":"2025","unstructured":"Su P, Chen C, Sun Y (2025) Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res. https:\/\/doi.org\/10.1186\/s13048-025-01621-6","journal-title":"J Ovarian Res"},{"key":"2015_CR78","doi-asserted-by":"publisher","first-page":"1142041","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gao S, Ye C, Zhao W (2023) Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol 13:1142041. https:\/\/doi.org\/10.3389\/fcimb.2023.1142041","journal-title":"Front Cell Infect Microbiol"},{"key":"2015_CR79","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033572","author":"CT Tay","year":"2024","unstructured":"Tay CT, Mousa A, Vyas A, Pattuwage L, Tehrani FR, Teede H (2024) 2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.123.033572","journal-title":"J Am Heart Assoc"},{"key":"2015_CR80","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, Andersen M, Azziz R, Balen A, Baye E, Boyle J, Brennan L, Broekmans F, Dabadghao P, Devoto L, Dewailly D, Downes L, Fauser B, Franks S, Garad RM, Gibson-Helm M, Harrison C, Hart R, Hawkes R, Hirschberg A, Hoeger K, Hohmann F, Hutchison S, Joham A, Johnson L, Jordan C, Kulkarni J, Legro RS, Li R, Lujan M, Malhotra J, Mansfield D, Marsh K, McAllister V, Mocanu E, Mol BW, Ng E, Oberfield S, Ottey S, Pe\u00f1a A, Qiao J, Redman L, Rodgers R, Rombauts L, Romualdi D, Shah D, Speight J, Spritzer PM, Stener-Victorin E, Stepto N, Tapanainen JS, Tassone EC, Thangaratinam S, Thondan M, Tzeng CR, van der Spuy Z, Vanky E, Vogiatzi M, Wan A, Wijeyaratne C, Witchel S, Woolcock J, Yildiz BO (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 110:364\u2013379. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.004","journal-title":"Fertil Steril"},{"issue":"1","key":"2015_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","volume":"8","author":"H Teede","year":"2010","unstructured":"Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome\u202f: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8(1):41","journal-title":"BMC Med"},{"key":"2015_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100431","author":"K Thakur","year":"2025","unstructured":"Thakur K, Singh B, Kumar S, Sharma D, Sharma AK, Jindal R, Kumar R (2025) Potential of probiotics and postbiotics in aquaculture: connecting current research gaps and future perspectives. Microbe. https:\/\/doi.org\/10.1016\/j.microb.2025.100431","journal-title":"Microbe"},{"key":"2015_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"C Tong","year":"2022","unstructured":"Tong C, Wu Y, Zhang L, Yu Y (2022) Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway. Front Endocrinol (Lausanne) 13:1\u201310. https:\/\/doi.org\/10.3389\/fendo.2022.1091147","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR85","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molonc.2015.12.013","volume":"10","author":"K Viktorsson","year":"2016","unstructured":"Viktorsson K, Shah CH, Juntti T, H\u00e5\u00e5g P, Zielinska-Chomej K, Sierakowiak A, Holmsten K, Tu J, Spira J, Kanter L, Lewensohn R, Ull\u00e9n A (2016) Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma. Mol Oncol 10:719\u2013734. https:\/\/doi.org\/10.1016\/j.molonc.2015.12.013","journal-title":"Mol Oncol"},{"key":"2015_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y (2023) Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol (Lausanne) 14:1\u201328. https:\/\/doi.org\/10.3389\/fendo.2023.1191759","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2015_CR87","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.3892\/mmr.2017.7678","volume":"16","author":"F Wang","year":"2017","unstructured":"Wang F, Wang S, Zhang Z, Lin Q, Liu Y, Xiao Y, Xiao K, Wang Z (2017) Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome. Mol Med Rep 16:8164\u20138170. https:\/\/doi.org\/10.3892\/mmr.2017.7678","journal-title":"Mol Med Rep"},{"key":"2015_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1273542","author":"K Wang","year":"2023","unstructured":"Wang K, Li Y, Chen Y (2023) Androgen excess: a hallmark of polycystic ovary syndrome. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2023.1273542","journal-title":"Front Endocrinol"},{"key":"2015_CR89","doi-asserted-by":"publisher","first-page":"101650","DOI":"10.1016\/j.fochx.2024.101650","volume":"23","author":"L Wei","year":"2024","unstructured":"Wei L, Wang B, Bai J, Zhang Y, Liu C, Suo H, Wang C (2024) Postbiotics are a candidate for new functional foods. Food Chemistry X 23:101650. https:\/\/doi.org\/10.1016\/j.fochx.2024.101650","journal-title":"Food Chemistry X"},{"key":"2015_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J (2022) Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthcare Eng. https:\/\/doi.org\/10.1155\/2022\/9240569","journal-title":"J Healthcare Eng"},{"key":"2015_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01337-0","author":"H Yan","year":"2024","unstructured":"Yan H, Wang L, Zhang G, Li N, Zhao Y, Liu J, Jiang M, Du X, Zeng Q, Xiong D, He L, Zhou Z, Luo M, Liu W (2024) Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: from mechanisms to therapeutic strategies. Reprod Biol Endocrinol. https:\/\/doi.org\/10.1186\/s12958-024-01337-0","journal-title":"Reprod Biol Endocrinol"},{"key":"2015_CR92","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cmet.2020.06.017","volume":"32","author":"H Yoon","year":"2020","unstructured":"Yoon H, Spinelli JB, Zaganjor E, Wong SJ, German NJ, Randall EC, Dean A, Clermont A, Paulo JA, Garcia D, Li H, Rombold O, Agar NYR, Goodyear LJ, Shaw RJ, Gygi SP, Auwerx J, Haigis MC (2020) PHD3 loss promotes exercise capacity and fat oxidation in skeletal muscle. Cell Metab 32:215-228.e7. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.017","journal-title":"Cell Metab"},{"key":"2015_CR93","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.clinthera.2024.04.008","volume":"46","author":"J Yu","year":"2024","unstructured":"Yu J, Wang Y, Ragueneau-Majlessi I (2024) Risk of enzyme- and transporter-mediated drug interactions with drugs approved by the US food and drug administration in 2022: a detailed analysis of in vitro and clinical data available in new drug application reviews. Clin Ther 46:499\u2013508. https:\/\/doi.org\/10.1016\/j.clinthera.2024.04.008","journal-title":"Clin Ther"},{"key":"2015_CR94","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1007\/s00253-018-9217-9","volume":"102","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Lv J, Pan L, Zhang Y (2018) Roles and applications of probiotic Lactobacillus strains. Appl Microbiol Biotechnol 102:8135\u20138143. https:\/\/doi.org\/10.1007\/s00253-018-9217-9","journal-title":"Appl Microbiol Biotechnol"},{"key":"2015_CR95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13048-025-01623-4","volume":"18","author":"K Zhang","year":"2025","unstructured":"Zhang K, Wang X, Liu F, Lin H, Wang Y, Zhao M, Wang X, Chu Y, Xu L (2025) MiR-34a-5p modulation of polycystic ovary syndrome via targeting the NOTCH signaling pathway. J Ovarian Res 18:55. https:\/\/doi.org\/10.1186\/s13048-025-01623-4","journal-title":"J Ovarian Res"},{"key":"2015_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023a) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16:9. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"key":"2015_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023b) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16:1\u201317. https:\/\/doi.org\/10.1186\/s13048-022-01091-0","journal-title":"J Ovarian Res"},{"key":"2015_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EC-19-0522","volume":"9","author":"L Zhou","year":"2020","unstructured":"Zhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, Yu C, Cai Z (2020) Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect 9:63\u201373. https:\/\/doi.org\/10.1530\/EC-19-0522","journal-title":"Endocr Connect"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02015-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-02015-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-02015-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:04:52Z","timestamp":1766055892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-02015-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-02015-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}